PML regulates p53 acetylation and premature senescence induced by oncogenic Ras

Nature

Volumn 406, Issue 6792, 2000, Pages 207-210

  Pearson, Mark ^a   Carbone, Roberta ^a   Sebastiani, Carla ^b   Cloce, Mario ^a   Fagloll, Marta ^b   Saito, Shin'Ichi ^c   Higashimoto, Yulchiro ^c   Appella, Ettore ^c   Minucci, Saverio ^a   Pandolfi, Pier Paolo ^d   Pellcci, Pier Giuseppe ^a,b  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

^c NATIONAL CANCER INSTITUTE   (United States)

^d Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; PROTEIN P53;

ACETYLATION; ANIMAL CELL; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; EMBRYO; FIBROBLAST; GENE CONTROL; GENE EXPRESSION; GENE INDUCTION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; MOUSE; NONHUMAN; ONCOGENE RAS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SENESCENCE; TUMOR SUPPRESSOR GENE;

ACETYLATION; ANIMALS; CELL AGING; CELL NUCLEUS; GENES, RAS; HUMANS; LYSINE; MICE; NEOPLASM PROTEINS; NUCLEAR PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

ANIMALIA;

EID: 0034644274     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/35018127     Document Type: Article

References (30)

1. Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D. & Lowe, S. W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 andp16INK4a. Cell 88, 593-602 (1997).
2. Giaccia, A. J. & Kastan, M. B. The complexity of 53 modulation: emerging patterns from divergent signals. Genes Dev. 12, 2973-2983 (1998).
3. de The, H., Chomienne, C., Lanotte, M., Degos, L. & Dejean, A. The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus, Nature 347, 558-561 (1990).
4. Borrow, J., Goddard, A. D., Sheer, D. & Solomon, E. Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17. Science 249, 1577-1580 (1990).
5. Fagioli, M. et al. Cooperation between the R1NG + B1-B2 and coiled-coil domains of PML is necessary for its effects on cell survival. Oncogene 16, 2905-2913 (1998).
6. Le, X. F., Yang, P. & Chang, K. S. Analysis of the growth and transformation suppressor domains of promyelocytic leukemia gene, PML. J. Biol. Chem. 271, 130-135 (1996).
7. Liu, J. H., Mu, Z. M. & Chang, K. S. PML suppresses oncogenic transformation of NIH/3T3 cells by activated neu. J. Exp. Med. 181, 1965-1973 (1995).
8. Wang, Z. G. et al. Role of PML in cell growth and the retinoic acid pathway. Science 279, 1547-1551 (1998).
9. Dimri, G. P. et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl Acad. Sci. USA 92, 9363-9367 (1995).
10. Dyck, J. A. et al. A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell 76, 333-343 (1994).
11. Metz, T., Harris, A. W. & Adams, J. M. Absence of p53 allows direct immortalization of hematopoietic cells by the myc and raf oncogenes. Cell 82, 29-36 (1995).
12. Harvey, M. et al. In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. Oncogene 8, 2457-2467 (1993).
13. Alcorta, D. A. et al. Involvement of the cyclin-dependent kinase inhibitor p16 (1NK4a) in replicative senescence of normal human fibroblasts. Proc. Natl Acad. Sci. USA 93, 13742-13747 (1996).
14. el-Deiry, W. S. et al. WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825 (1993).
15. Sherr, C. J. & Weber, J. D. The ARF/p53 pathway. Curr. Opin. Genet. Dev. 10, 94-99 (2000).
16. Sakaguchi, K. et al. DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev. 12, 2831-2841 (1998).
17. Liu, L. et al. p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage. Mol. Cell. Biol. 19, 1202-1209 (1999).
18. Doucas, V.,Tini, M., Egan, D. A. & Evans, R. M. Modulation of CREB binding protein function by the promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling. Proc. Natl Acad. Sci. USA 96, 2627-2632 (1999).
19. Grignani, F. et al. High-efficiency gene transfer and selection of human hematopoietic progenitor cells with a hybrid EBV/retroviral vector expressing the green fluorescence protein. Cancer Res. 58, 14-19 (1998).
20. Gu, W. & Roeder, R. G. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90, 595-606 (1997).
21. Lill, N. L., Grossman, S. R., Ginsberg, D., DeCaprio, J. & Livingston, D. M. Binding and modulation of p53 by p300/CBP coactivators. Nature 387, 823-827 (1997).
22. LaMorte, V. J., Dyck, J. A., Ochs, R. L. & Evans, R. M. Localization of nascent RNA and CREB binding protein with the PML-containing nuclear body. Proc. Natl Acad. Sci. USA 95, 4991-4996 (1998).
23. Ishov, A. M. et al. PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1. J. Cell Biol. 147, 221-234 (1999).
24. Zhong, S. et al. Role of SUMO-1 modified PML in nuclear body formation. Blood 95, 2748-2752 (2000).
25. Quignon, F. et al. PML induces a novel caspase-independent death process. Nature Genet. 20, 259-265 (1998).
26. Sherr, C. J. Tumor surveillance via the ARF-p53 pathway. Genes Dev. 12, 2984-2991 (1998).
27. Livingstone, L. R. et al. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70, 923-935 (1992).
28. Yin, Y., Tainsky, M. A., Bischoff, F. Z., Strong, L. C. & Wahl, G. M. Wild-type p53 restores cell-cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 70, 937-948 (1992).
29. Zhong, S. et al. A role for PML and the nuclear body in genomic stability. Oncogene 18, 7941-7947 (1999).
30. Grignani, F. et al. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia. Nature 391, 815-818 (1998).